-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Genotypes in matrix metalloproteinase 9 are a risk factor for COPD
(1861) Views (394) Full article downloads
Authors: Yohannes Tesfaigzi, Orrin B Myers, Christine A Stidley, Kurt Schwalm, Maria Picchi, et al
Published Date May 2006
Volume 2006:1(3) Pages 267 - 278
DOI: http://dx.doi.org/10.2147/COPD.S
Yohannes Tesfaigzi1, Orrin B Myers2, Christine A Stidley2, Kurt Schwalm1, Maria Picchi1, Richard E Crowell3, Frank D Gilliland4, Steven A Belinsky1
1Lovelace Respiratory Research Institute, Albuquerque, NM, USA; 2Department of Internal Medicine, New Mexico Center for Environmental Health Sciences, University of New Mexico, Albuquerque, USA; 3Department of Internal Medicine, University of New Mexico, and Pulmonary Section, New Mexico VA Health Care System, Albuquerque, NM, USA; 4Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA
Abstract: A growing body of evidence indicates that matrix metalloproteinases (MMPs) play a role in the pathogenesis of COPD. Therefore, we conducted a candidate gene association study of 4 promoter polymorphisms that are known to modify expression levels of the MMP-1, MMP-2, and MMP-9 genes and a Gln279Arg polymorphism in exon 6 of MMP-9 that modifies the substrate-binding region. We examined the association of each variant and haplotypes in 385 male veterans with greater than 20 pack-years of cigarette smoking whose COPD status was characterized using spirometry. The association of these polymorphisms was also examined with decline of pulmonary function in a subset of participants. Only the 279Arg variant was more common in participants with COPD and the homozygous variant was associated with a 3-fold increased risk for COPD. In the haplotype analysis, the haplotype comprising the 249Arg and the CA promoter polymorphism within the MMP-9 gene was associated with risk, suggesting that either 279Arg or a linked variant on this haplotype underlies the association. No association of this polymorphism was found with decline in pulmonary function. These studies show that variants of the MMP-9 gene are associated with COPD in this cohort of veterans.
Keywords: metalloproteinase, smoking, pulmonary function, single nucleotide polymorphism, molecular epidemiology
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




